Last updated on August 2017

A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough


Brief description of study

A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough

Detailed Study Description

The purpose of this study is to determine the effectiveness of three doses of orvepitant, taken once a day, in the treatment of chronic refractory cough.

Clinical Study Identifier: TX151852

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Renee Smith

University of South Florida- Asthma, Allergy, and Immunology Clinical Research Unit
Tampa, FL USA
  Connect »